← Eichor
Condition: Phthisis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Phthisis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB
Phase 2 · 11 location(s) · University College, London · NCT06114628Novel Triple-dose Tuberculosis Retreatment Regimen
Phase 3 · 1 location(s) · Institute of Tropical Medicine, Belgium · NCT04260477Short Course Regimen in Low Risk Active Tuberculosis- a Multicenter, Randomized, Active-controlled, Trial
Phase 3 · 8 location(s) · Kaohsiung Veterans General Hospital. · NCT06727864Parent Study Name: Pulmonary Rehabilitation to Reduce Post-Tuberculosis Morbidity (TB Pure)
NA · 2 location(s) · Johns Hopkins University · NCT07164742Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis
Phase 2 · 29 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06192160Respiratory Health and Wellbeing Post Pulmonary Tuberculosis
Phase N/A · 1 location(s) · Liverpool School of Tropical Medicine · NCT07178860Sorfequiline-based Regimens in Adults With Newly Diagnosed Drug-sensitive Pulmonary TB
Phase 2 · 11 location(s) · Global Alliance for TB Drug Development · NCT07672405A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients
Phase 3 · 2 location(s) · Shanghai Jiatan Pharmatech Co., Ltd · NCT05824871Bactericidal Activity of TBD09 in Combination With Other Drugs in Pulmonary Tuberculosis
Phase 2 · 13 location(s) · Gates Medical Research Institute · NCT07525427Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath
Phase N/A · 1 location(s) · ChromX Health · NCT06528418ATORvastatin in Pulmonary TUBerculosis: a POPulation PharmacoKinetics -PharmacoDynamics Sub-study (ATORTUB popPK-PD)
Phase 2 · 3 location(s) · Obafemi Awolowo University Teaching Hospital · NCT07303699Seoul National University Airway Registry
Phase N/A · 3 location(s) · Seoul National University Hospital · NCT02527486A PAN-USR TB Multi-Center Trial
Phase 3 · 3 location(s) · Shenzhen Third People's Hospital · NCT06905522Pre- and Post-treatment Lung Microbiota, Metabolome and Immune Signatures at the Site of Disease in Patients With Active
Phase N/A · 3 location(s) · University of Stellenbosch · NCT04700579Optimizing(O) RIfapentine-based(RI) Regimen and shortENing(EN) the Treatment of Drug-sensitive Tuberculosis(T)
Phase 2/Phase 3 · 6 location(s) · Huashan Hospital · NCT05401071Phase 2 Trial to Evaluate the Safety and Tolerability and Early Bactericidal Activity of RESP30TB in Tuberculosis
Phase 2 · 1 location(s) · Thirty Respiratory Limited · NCT07073638Remimazolam for Bronchoscopy in High-Risk Patients
Phase 4 · 2 location(s) · First Affiliated Hospital of Zhejiang University · NCT07395596Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis
Phase 3 · 6 location(s) · National University Hospital, Singapore · NCT05473520A Systemic Screening for TB Disease in High-risk Groups in Barcelona
Phase N/A · 1 location(s) · Fundació Institut Germans Trias i Pujol · NCT06706596Bactericidal Activity and Safety of Nicotinamide in Combination With Bedaquiline, Pretomanid, and Linezolid in Drug-susc
Phase 2 · 4 location(s) · Gates Medical Research Institute · NCT07517445A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis
Phase 3 · 35 location(s) · Otsuka Pharmaceutical Development & Commercialization, Inc. · NCT07209761Effect of Peer-led Educational Intervention on Treatment Outcomes Among Adults With Drug-susceptible Pulmonary Tuberculo
NA · 1 location(s) · Bahirdar University · NCT07387601PanACEA - STEP2C -01
Phase 2 · 10 location(s) · Michael Hoelscher · NCT05807399ATORvastatin in Pulmonary TUBerculosis
Phase 2 · 8 location(s) · Obafemi Awolowo University Teaching Hospital · NCT06199921Rehabilitation of People With Post-tuberculosis Lung Disease
NA · 2 location(s) · Centro Universitário Augusto Motta · NCT06127641A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets
Phase 2 · 7 location(s) · WestVac Biopharma Co., Ltd. · NCT07170800Efficacy Safety BaiDiZiYin ShenQiYiFei Adjunctive Treatments Pulmonary Tuberculosis
Phase 4 · 1 location(s) · Beijing Chest Hospital · NCT06403943Safety and Efficacy of Ear Acupuncture for Antituberculosis Drug-Related Nausea and Vomiting
NA · 1 location(s) · Indonesia University · NCT07271225DoseTB-individualised Dosing by Model-informed Precision Dosing for Pulmonary Tuberculosis
Phase N/A · 2 location(s) · Karolinska Institutet · NCT06585358A Study of the Early Effects, Safety, and Acceptability of Oral Alpibectir in Combination With Ethionamide
Phase 2 · 1 location(s) · TASK Applied Science · NCT06748937
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.